fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Aarti Drugs Ltd

Aarti Drugs Ltd

Updated on November 12, 2019

Stock/Share Code - AARTIDRUGS

Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.(Source : 201903 Annual Report Page No: 93)

Below is the details of AARTIDRUGS Aarti Drugs Ltd

Market Cap₹1,085 Cr.
Current Price ₹525.1 as on 15 Nov 19
52 Week High / Low Price₹707 / ₹419.3
Face Value₹10
Stock P/E12.55
Book Value₹222.56
Dividend Yield0.22 %
ROCE17.00 %
ROE17.80 %
Sales Growth (3yrs)10.58 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros:
Cons: The company has delivered a poor growth of 8.40% over past five years.

Aarti Drugs Ltd Price Chart

Aarti Drugs Ltd Price Chart

Aarti Drugs Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹176.45 31.89 ₹43,149.26 Cr. 0.98 ₹272.44 Cr. 1.78 16.84 1162.88 28.51
2. Lupin ₹742.25 41.91 ₹33,537.93 Cr. 0.67 ₹303.05 Cr. 49.46 14.59 4418.38 9.97
3. Vinati Organics ₹1,929.75 36.23 ₹10,892.07 Cr. 0.33 ₹82.36 Cr. 28.19 11.94 290.74 45.83
4. Jubilant Life ₹493.4 9.57 ₹6,996.46 Cr. 0.68 ₹184.98 Cr. -15.08 4.97 2181.86 15.26
5. Suven Life Scie. ₹310.7 43.81 ₹3,305.53 Cr. 0.58 ₹26.21 Cr. 0.73 3.82 198.99 16.95
6. Granules India ₹123.5 8.59 ₹2,299.67 Cr. 1.11 ₹83.24 Cr. 60.69 31.34 595.27 14.75
7. Sequent Scien. ₹67.35 33.53 ₹1,905.84 Cr. 0.26 ₹11.46 Cr. 249.39 18.23 278.02 9.21
8. Aarti Drugs 12.55 ₹1,084.5 Cr. 0.22 ₹21.57 Cr. -3.66 5.25 370.02 17.00

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Aarti Drugs Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales287263272229288308315352320351433370
YOY Sales Growth %11.26%2.63%-8.65%-14.84%0.54%16.99%15.92%53.48%10.86%13.77%37.32%5.25%
Expenses240224225196244257261301274300380318
Material Cost %64.58%64.75%62.03%60.99%64.15%62.74%62.87%67.85%65.71%65.3%70.37%65.35%
Employee Cost %4.13%4.32%4.7%5.19%4.29%4.2%4.22%3.7%4.01%3.73%3.29%3.84%
Operating Profit474047334451545046515252
OPM %16%15%17%14%15%16%17%14%14%15%12%14%
Other Income010000110050
Interest89888899910109
Depreciation999999101010101011
Profit before tax302230162733373227313832
Tax %33%27%28%32%33%33%38%31%32%32%32%33%
Net Profit201622111822232218212622
EPS in Rs8.306.938.584.437.569.239.469.407.658.9711.319.19
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales3113774604966598269721,0871,0761,0891,1401,4541,473
Sales Growth %12.46%21.17%22.24%7.86%32.8%25.25%17.68%11.88%-1.08%1.23%4.75%27.51%%
Expenses2723183984325797028229159009109551,2521,271
Material Cost %66.72%65.58%67.6%67.2%67.4%65.91%67.01%67.07%65.17%62.93%61.43%66.36%%
Manufacturing Cost %12.35%11.07%10.65%11.7%12.73%11.99%10.16%10.83%11.37%12.48%14.22%12.79%%
Employee Cost %3.16%2.96%2.96%3.32%3.53%3.13%2.93%3.01%3.43%3.93%3.96%3.25%%
Other Cost %5.2%4.76%5.16%4.73%4.22%4%4.45%3.24%3.68%4.22%4.16%3.66%%
Operating Profit3959636580124150172176179185203202
OPM %13%16%14%13%12%15%15%16%16%16%16%14%14%
Other Income201102-11104165
Interest13251716253137424738364138
Depreciation10111418242628313637384042
Profit before tax1823443132668610093108112128128
Tax %27%35%40%29%30%31%28%22%29%30%35%32%
Net Profit13152622224562786675738786
EPS in Rs5.426.1710.728.878.8717.8524.3832.0426.0031.6431.1337.0037.12
Dividend Payout %16%23%22%27%27%27%26%41%25%3%3%3%

Compounded Sales Growth

  • 10 Years:: 14.47%
  • 5 Years:: 8.40%
  • 3 Years:: 10.58%
  • TTM:: 16.61%

Compounded Profit Growth

  • 10 Years:: 18.84%
  • 5 Years:: 6.73%
  • 3 Years:: 8.52%
  • TTM:: 1.42%

Return on Equity

  • 10 Years:: 20.36%
  • 5 Years:: 20.23%
  • 3 Years:: 18.50%
  • Last Year:: 17.80%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital121212121212122424242424
Equity Capital11.7111.7111.7112.1112.1112.1112.1124.2224.2223.8623.5823.58
Reserves97108129144164196239279326363410495
Borrowings205178178222272296342435465448517471
Other Liabilities818890138164216257228240281366391
Trade Payables63.3366.4363.1577.3693.78131.89150.18150.19164.18170.3239.67228.43
Total Liabilities3953874095166137208509671,0551,1161,3161,380
Fixed Assets159179184224274291373431463542564586
Gross Block233.59267.26287.48345.8439.38479.05545.29665.09690.74805.25862.31922.44
Accumulated Depreciation74.4787.88103.95121.59165.84187.82172.76233.61227.97262.93298.72336.77
CWIP15131031381334142832
Investments342121257551111181719
Other Assets188185200257329411464511547541708743
Inventories61.5557.258.5883.1697.91140.92126.73153.36167.05188.75254.1227.71
Trade receivables97.01106.33118.45125.83180.6215.67276.52307.59321.2278.27365.23436.9
Cash Equivalents2.632.73.653.594.942.884.43.434.543.914.85
Loans n Advances26.4918.9119.6535.4943.4548.7449.5942.3649.2858.4573.6565.55
Other Assets etc0.04008.632.262.567.034.254.7411.7710.788.26
Total Assets3953874095166137208509671,0551,1161,3161,380

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity3161452844729510712517462147
Profit from operations41.9960.3676.9764.8982.11119.75146.07168.8171.04175.98183.27197.88
Working Capital Changes-7.185.45-19.42-27.76-30.73-33.89-24.09-47.03-25.7517.93-99.42-21.68
Taxes paid-3.86-4.95-12.65-8.73-6.95-13.55-26.55-14.94-20.02-19.51-21.92-28.91
Cash from Investing Activity-32-6-25-74-48-58-105-102-87-96-71-59
Fixed Assets Purchased-18.38-19.26-23.42-70.42-47.26-60-106.51-96.62-88.07-98.09-71.93-71.79
Fixed Assets Sold0.070.5900.03000.05001.68011.2
Capital WIP00-1.42000000000
Investments purchased-12.1800-3.23-1.3300-6.50-0.400
Investments sold012.170001.790.4600000
Cash from Financing Activity-1-54-19453-1611-5-37-789-87
Proceeds from Shares00.211.89000000000
Proceeds from Borrowings18.4521.956.1469.8538.0222.658.1770.392410.8669.13.4
Repayment of Borrowings0-50.78-6.970-4.280000000
Interest Paid-19.13-22.65-16.7-15.64-25.31-28.03-33.49-38.88-43.28-34.48-33.01-37.56
Dividends Paid0-3.07-3.51-9.08-5.45-10.9-13.92-22.67-23.610-2.43-2.43
Net Cash Flow-201-0-0-22-11-0-01

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %10%16%20%14%14%20%22%21%18%17%17%17%
Debtor Days11410394931009510410310993117110
Inventory Turnover5.236.347.957.007.286.917.267.766.716.125.156.04

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Aarti Drugs Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.